ethinyl estradiol-norgestrel combination has been researched along with Activated Protein C Resistance in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burggraaf, J; de Kam, ML; Kluft, C; Meijer, P; Ménard, J; Rad, M; Sitruk-Ware, RL; Sivin, I | 1 |
Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
Bannemerschult, R; Düsterberg, B; Endrikat, J; Gerlinger, C; Junge, W; Noah, M; Ruebig, A; Schmidt, W | 1 |
2 trial(s) available for ethinyl estradiol-norgestrel combination and Activated Protein C Resistance
Article | Year |
---|---|
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
Topics: Activated Protein C Resistance; Adolescent; Adult; Blood Coagulation Factors; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrinolysis; Humans; Immunoradiometric Assay; Norprogesterones; Plasminogen; Protein C; Sex Hormone-Binding Globulin | 2006 |
Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Factor V; Female; Humans; Mutation; Norethindrone; Polymerase Chain Reaction; Prospective Studies; Protein C; Venous Thrombosis | 2001 |
1 other study(ies) available for ethinyl estradiol-norgestrel combination and Activated Protein C Resistance
Article | Year |
---|---|
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |